HSP90AA1 and cancer: Cancer cells greatly rely on members of the HSP70 and HSP90 chaperone families for their growth and survival [5, 88], consequently, significant efforts have been invested to design small molecule inhibitors specific for these ATPases as novel anticancer therapeutics.